TOURTuniu Corporation Sponsored ADR
- Next report
- Dec 4
- Friday, in 22 days · time not announced yet
- Price
- $4.95
- −0.40% today · $56.2M cap
Past and upcoming reports
2
| Dec 4, 2026 | Sep 30, 2026 | Time not announced yet | n/a | not yet | |
| Jun 11, 2026 | Mar 31, 2026 | Time not given | n/a | not recorded | −10.59%2d |
Pre-earnings read
No pre-earnings read for this report
None for this company right now.
After the report
Jun 11, 2026 report
Tuniu shares drop 5.2% post-Q1 report amid absent EPS data and cautious outlook
Tuniu's stock declined 5.2% following its Q1 2026 earnings release without reported EPS, reflecting investor caution despite 13% revenue growth and strong growth outlook. Valuation remains attractive but quality metrics are weak, with insider buying and buy-tilted analyst consensus supporting a watchful stance.
Reported against expected
EPS data not available. no beat or miss confirmed. revenue grew 13% YoY in Q1 2026.
Guidance
Management projects modest revenue growth for Q2 2026, signaling cautious optimism.
How the stock reacted
Stock declined 5.2% on June 11, closing at $4.56, with volume of 47,271 shares.
What changed
Revenue rose 13% YoY in Q1 2026. stock fell 5.2% post-earnings without EPS data.
What the price now assumes
Market discounts uncertainty from missing EPS and weak quality despite growth and cheap valuation.
What it means for the business
Maintain neutral bias. monitor Q2 revenue guidance and EPS disclosure for clearer growth validation.
The next one to three months, as we saw it then
Better case30%
Positive Q2 guidance and EPS disclosure confirm growth acceleration, triggering stock rebound.
Base case50%
Modest Q2 growth with delayed EPS clarity keeps stock range-bound amid valuation support.
Worse case20%
Weak Q2 guidance or negative EPS surprise triggers further share price decline and investor concern.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Consider entry if Q2 revenue growth exceeds 13% and EPS is reported positively. avoid if EPS remains undisclosed or guidance weakens.
Scenario odds are a judgement, not measured.